Macrop hag ic ntyofa sciitis was first reported in 1998. This disease manifests as diffuse myalgia and chronic f atig ue. Its pathophys iology has been traced to the presence ofan alumin um adj uvant used in vaccines aga inst hepatitis A and B virus and teta nus toxo id; the adjuvant aggregates at the site of injection. One-third ofpat ients with macrophag ic myofasciitis develop autoimm une disease. Vocal fo ld deposits have been described in autoimmune diseases such as sarcoidosis, systemic lupus erythematosus, multiple sclerosis, rheumatoid arthritis, Sjogren s syndrome, and Hashimoto sthyroiditis. We report what to the best ofour knowl edge is the first published case ofvocalfo ld depo sits in ma crophagic niyofa sciitis.
Introduction
Macrophagic myofasciitis was first reported by Gherardi et al in 1998 .J Since then, more than 200 defini te cases have been identified in France, and a few iso lated cases have been recor ded in other cou ntries. 2 Th e co ndition manifests as diffuse myalgia and chronic fatig ue. In about half of affected patients, symp toms meet the Oxford criteria} for chro nic fatigue syndro me as well as the cri teria established by the Centers for Disease Co ntro l and Prevent ion. ' In this article, we describe what to the best of our know ledge is the first reported case of voca l fold deposi ts in a patient with macrophagic myofasciitis.
Case report
A 46-year-old man was refer red to our oto lary ngology service in Ire land with a 3-month history of hoarseness and intermittent aphon ia. Two year s ear lier, he had been diagno sed with macrophagic myofasciitis. He was a nonsmoker, and he worked as a university lecturer.
Direct laryngoscopy revealed the presence of several whitish-yellow, bandlike lesions in the submucosal space, approximately at the middle of the me mbranous portion of the vocal fold ( figure 1 ). The lesions were bilateral but not exactly opposi te each other. They were lying transversely, and they caused a slight co nvexity of the upper vocal fold surface . On stroboscopy, reduced mucosal wave and vibration amplitude were noted at the site of the lesions. Histologic exa mina tio n of these submucosal nodules revealed the class ic appearance of a rheumatoid lesion with central fibrinoi d necros is and peripheral histiocytic palisading (figure 2). The patien t declined surgical intervention. He was prescribed a course of ora l steroids, and his voice quality improved significantly.
During follow -up, all autoimmune sero logic tests-including tests for anti-s mooth-muscle antibodies, antimitochondrial antibo dies, gastric parietal cell antibodies, rheu matoid factor, anti-Rho, anti-La, SS-A , SS-B, RNP, and antinuclear antibodies-were negative.
Discussion
The histologic characteristics of the lesions in our patient appeared to be the same as those of subcutaneous rheumatoid nodules. Also, the lesions appeared to be the same as those described by Woo et aP and the same as the autoimmune deposits described by Hosako-Naito et al."In our patient, all autoimmune antibodies and serology were negative.These vocal fold deposits have not been previo usly descri bed in patients with macroph agic myofasciitis. One-third of pat ient s with macrophagic myo fasci itis devel op an autoimmune disease.' Even in the absence of overt autoimmune disease, affected patients may show subtle sig ns of chroni c immune stimulation. Many of these patients are in the HLA-DRBl *OI group, a phenotype at risk of developing polymyal gia rheumatica and rheumatoid arthriti s. Macrophagic myofasciiti s is characterized by a stereotyped and immunologicall y acti ve lesion seen on deltoid muscle biop sy.
Th e etiology of macrophagi c myofasciitis remained obscure until 2001. 7 At that time, electron microscopy,microanalytical studies, experimental procedures, and an epidemiologic study demonstrated that the lesion is caused by the presenc e of an aluminum adjuv ant used in vaccines against hepatiti s A and B virus and tetanus toxoid ; the aluminum rem ains accumulated at the site of injection. 2 Aluminum hydro xide is known to potently stimulate the immune system. It is plau sibl e that persistent immune activation that fails to "switch off' can lead to vocal fold depo sits.
Rheumatoid nodules are most likel y to appe ar in area s subject to repeated microtrauma (e.g., the elbows) ." In the laryn x, contact forces are grea test during vibration at the midpoint ofthe memb ranou s vocal fold s, which might explain why the rheum atic depo sits in our patient developed at this specific site and not elsewh ere. We also postulate that pati ent s who use their voice profession ally-such as our patient, who was a lecturer-may be more prone to dev elop ing these lesion s."
Two other diseases of inte rest as differential diagnoses of vocal fold depo sits are amyloidosis and lipoid proteinosis (Urbach-Wiethe 's disease) :
• Amyloidosis is an uncommon disease characterized by extracellular fibrillar proteins that stain with Con go red.? The mo st common sites in the larynx are the ventricle, false vocal fold s, true vocal fold s, epi glotti s, aryepiglottic fold s, subglottis, and trach ea, in that order.'?
• Lipoid proteinosis is a rare genetic defect associated with depo sition of hyaline material in various tissues, including the skin , mucous membranes (especially in the upperrespiratory tract), and internal organ s. Th e deposit s are always periodic acid-Schiff-positive and often sudanophil-pos irive." Laryngo scopi c findings include (1) thick ened vocal fold s, often with irregula r borders, and (2) when depo sits are abundant , decreased abduction, adduction, or even immobilization of the vocal fold s. In the laryn x, the depo sits may also affect the epiglotti s, aryepiglottic fold s, and false vocal fold s. Minor lesion s on the vocal fold margin s may look like submucosa l autoimmune deposits.
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The first symptom of autoimmune disease has been reported to be hoa rseness or other chan ges in the quality ofv oice.I-" Otol aryngolo gists play an impo rtant role in the care and investigation of such patients because immune-mediated vocal fold depo sits may, in fact , be the first presentation of these systemic diseases. To our knowledge, our ca se repre sents the first reported instance of immune-mediated vocal fold dep osits in a pati ent with macrophagic myofasciiti s.
